Herbs and plantsHeavy, swollen legs in the evening? What does horse chestnut do to your veins!
What do Natural Therapy Specialists write?
Fruit and seed extracts are said to improve circulation and speed up the absorption of fluid at the site of swelling.
Flower extracts are said to strengthen blood vessels, improve circulation, and reduce swelling; they are used, among other things, for swelling and phlebitis.
The dosage given by Henryk Różański applies to preparations with a specified aescin content.
The ready-made preparations listed include tablets, capsules, coated tablets, gels, ointments, and ampoules standardized for aescin content.
Extracts from shoots and bark are described as reducing swelling.
Horse chestnut leaves increase blood clotting, and for nausea after taking a fruit preparation, Henryk Różański recommends reducing the dose or taking it after a meal.
What does scientific research from PubMed · Europe PMC say?
We selected 5 studies with the best, positive results. This is a selection, not a full review of all research.
Total number of studies on this topic in PubMed: 13.
Aim of the study: Safe and effective oral therapies for chronic venous insufficiency (CVI) would provide an important alternative to mechanical compression treatment.
Results: Overall, the RCTs indicated that HCSE improved symptoms in patients with CVI. Compared to placebo, HCSE reduced leg volume by 46.4 ml (95% CI, 11.3-81.4 ml) and increased the likelihood of improvement in leg pain 4.1-fold (95% CI, 0.98-16.8). Similarly, improvement probabilities were increased 1.5-fold (95% CI, 1.2-1.9) for edema and 1.7-fold (95% CI, 0.01-3.0) for itching. There was insufficient evidence to demonstrate HCSE's effect on leg fatigue/heaviness or calf cramps. Observational studies showed significant effectiveness regarding pain, edema, and leg fatigue/heaviness. No severe adverse events were reported, and HCSE did not significantly increase mild adverse events. Based on meta-analyses of RCTs and observational studies, HCSE appears to be an effective and safe treatment for CVI. Further RCTs and carefully conducted large-scale observational studies are required to evaluate the long-term effectiveness and safety of HCSE in routine settings.
“Not stated” does not mean nobody paid — the database does not always record it.
Aim of the study: Diseases of the venous system are widespread disorders sometimes associated with modern civilisation and are among the major concerns of social and occupational medicine. This study was carried out to compare the efficacy (oedema reduction) and safety of compression stockings class II and dried horse chestnut seed extract (HCSE, 50 mg aescin, twice daily).
Results: Lower leg volume of the more severely affected limb decreased on average by 43.8 mL (n = 95) with HCSE and 46.7 mL (n = 99) with compression therapy, while it increased by 9.8 mL with placebo (n = 46) after 12 weeks therapy for the intention-to-treat group (95% CI: HCSE: 21.1-66.4; compression: 30.4-63.0; placebo: 40.0-20.4). Significant oedema reductions were achieved by HCSE (p = 0.005) and compression (p = 0.002) compared to placebo, and the two therapies were shown to be equivalent (p = 0.001); in this design, however, compression could not be proven as standard with regard to oedema reduction in the statistical test procedure. Both HCSE and compression therapy were well tolerated and no serious treatment-related events were reported. These results indicate that compression stocking therapy and HCSE therapy are alternative therapies for the effective treatment of patients with oedema resulting from chronic venous insufficiency.
“Not stated” does not mean nobody paid — the database does not always record it.
Aim of the study: Extracts from the seed of the horse chestnut (Aesculus hippocastanum L.) have traditionally been used to treat patients with chronic venous insufficiency and to alleviate its associated symptoms, including lower leg swelling. The efficacy of preparations that contain horse chestnut seed extract (HCSE) is believed to be due largely to an inhibitory effect on the catalytic breakdown of capillary wall proteoglycans.
Results: The efficacy of preparations that contain horse chestnut seed extract (HCSE) is believed to be due largely to an inhibitory effect on the catalytic breakdown of capillary wall proteoglycans. Aesculaforce is a fresh plant HCSE that is available as an oral tincture, as tablets (20 mg or 50 mg), and as topical gel. Four clinical trials in patients with chronic venous insufficiency and 1 study in patients with varicose veins demonstrated the effectiveness of these preparations through the objective measure of reduction in lower leg edema and the subjective alleviation of leg pain, heaviness, and itching. Safe, well tolerated, and acceptable to patients, the fresh plant HCSE preparation Aesculaforce offers a real alternative in the treatment of patients with mild to moderate venous insufficiency.
“Not stated” does not mean nobody paid — the database does not always record it.
Aim of the study: The effect of horse-chestnut seed extract (standardized on aescin; Venostasin retard) was assessed in a randomized placebo-controlled crossover double-blind trial of 22 patients with proven chronic venous insufficiency by measuring the capillary filtration coefficient and the intravascular volume of the lower leg by venous-occlusion plethysmography.
Results: Three hours after taking two capsules of Venostasin (600 mg; each capsule containing 50 mg aescin) the capillary filtration coefficient had decreased by 22%, whereas after administration of an identical-looking placebo capsule it rose but slightly over three hours. The difference in the effect of Venostasin and placebo is statistically significant (P = 0.006). The intravascular volume was reduced 5% more after Venostasin than the placebo, but this is not statistically significant. It is concluded that Venostasin has an inhibitory effect on oedema formation via a decrease in transcapillary filtration and thus improves oedema-related symptoms in venous diseases of the legs.
“Not stated” does not mean nobody paid — the database does not always record it.
Aim of the study: In a randomized placebo controlled parallel double blind study on 40 patients suffering from venous edema in chronic deep vein incompetence, the edema-reducing effect of horse chestnut seed extract vs. placebo, being the main test variable, was demonstrated by hydroplethysmography to be statistically significant.
Results: Additional measurements of leg circumference tendentially confirm the demonstrated clinical efficacy of verum, as is true for phlebody-namometric measurements (pressure at rest, minimum pressure, replenishment time) as well. By measuring the leg volume before and after edema provocation, it could be shown that the clinical benefit for the patient is present in all everyday situations (in movement as well as on sitting or standing). Treatment with an edema protective agent of the horse chestnut seed extract type is thus a useful adjunct to compression therapy. The tested preparation were well tolerated.
“Not stated” does not mean nobody paid — the database does not always record it.
What do orthomolecular medicine doctors write?
Sources (10)
- Henryk Różański — Kasztanowiec – Aesculus w fitoterapii
- Henryk Różański — Zioła podczas wędrówki, część I
- Efficacy, routine effectiveness, and safety of horsechestnut seed extract in the treatment of chronic venous insufficiency. A meta-analysis of randomized controlled trials and large observational studies. · Int Angiol 2002
- Comparison of leg compression stocking and oral horse-chestnut seed extract therapy in patients with chronic venous insufficiency. · Lancet 1996
- Treatment of patients with venous insufficiency with fresh plant horse chestnut seed extract: a review of 5 clinical studies. · Adv Ther 2006
- [Effects of horse-chestnut seed extract on transcapillary filtration in chronic venous insufficiency]. · Dtsch Med Wochenschr 1986
- Medical edema protection--clinical benefit in patients with chronic deep vein incompetence. A placebo controlled double blind study. · Vasa 1992
- Orthomolecular Medicine News Service — Six Approaches to Treat Knee Pain
- Orthomolecular Medicine News Service — Cholesterol-Lowering Drugs For Eight-Year-Old Kids?
- Orthomolecular Medicine News Service — Niacin Beats Statins: Supplements and Diet are Safer, More Effective
Pisaczek does not judge who is right. It shows what was written and where to read it. Every sentence above has its source.